ClinConnect ClinConnect Logo
Search / Trial NCT03408483

Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty

Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Jan 22, 2018

Trial Information

Current as of May 02, 2025

Completed

Keywords

Quadratus Lumborum Block

ClinConnect Summary

Currently, regional anesthesia techniques for total hip arthroplasty are limited. Fascia iliac blocks have been employed to provide analgesia for hip surgeries with blockade of the femoral, lateral femoral cutaneous, and obturator nerves via injection of local anesthetic in the iliacus fascia. In addition, lumbar plexus blocks have also been employed for post-operative analgesia, but the complexity of the block is high, and complications including epidural anesthesia are not infrequent. The quadratus lumborum block is an abdominal truncal block in which local anesthetic is deposited into th...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients undergoing total hip arthroplasty
  • 2. Adults 18 years of age and older
  • 3. Patients with an American Society of Anesthesiology (ASA) physical status classification of I, II or III
  • Exclusion Criteria:
  • 1. Patients with ASA physical status classification other than I, II, or III
  • 2. Patients with allergies/intolerances to local anesthetic
  • 3. Patients with pre-existing neurologic or anatomic deficits in the lower extremity on the side of the surgical site
  • 4. Patients with coexisting coagulopathy
  • 5. Patients that are pharmacologically anticoagulated will be excluded if placement of peripheral nerve block would be contraindicated according to ASRA (American Society for Regional Anesthesia) guidelines or if spinal anesthesia would be contraindicated according to guidelines

About University Of Alabama At Birmingham

The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.

Locations

Birmingham, Alabama, United States

Birmingham, Alabama, United States

Patients applied

0 patients applied

Trial Officials

Promil Kukreja, MD, PhD

Principal Investigator

UAB Department of Anesthesiology, Critical Care Division

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials